Policy

Latest News

fda workshop series banner
Part 3: BioRationality—FDA Webinar on Biosimilars Efficacy Testing Marks Major Step Forward

September 20th 2023

In the final part of a 3-part series, Sarfaraz K. Niazi, PhD, gives his take on the FDA's recent workshop dedicated to streamlining biosimilar development and his opinion on what the industry can learn from the webinar presenters.

Medicare Icon | © ClipartMax.com
Biologic Availability Contributes to Medicare Part B Drug Expenditure Growth

September 14th 2023

FDA workshop series thumbnail
Part 1: FDA Workshop Highlights Global Regulatory View on Biosimilar Development

September 13th 2023

doctor filling syringe | natali_mis - stock.adobe.com
The Growth of Biosimilars Continues to Create Hope for Lower Drug Costs

September 7th 2023

spilled pill bottle
BioRationality: First Price Reductions Under the IRA—3 Biologics With No Biosimilars

September 4th 2023

Video Interviews
Podcasts
cfb podcast banner
CfB podcast barrier
"SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars" with the CfB logo and an image of an eye
CfB podcast banner
CfB podcast banner
podcast banner
canadian flag on a mountain
CfB podcast banner
CfB podcast banner
CfB podcast banner

More News

© 2023 MJH Life Sciences

All rights reserved.